Lagap is a Swiss pharmaceutical Company, founded in 1959, that manufactures and markets branded generic medicines to Europe, Middle East, Africa and other emerging markets.
Our portfolio was carefully selected to answer to the public health needs, with evidence on safety and efficacy at the best affordable prices for everyone.
-
Attività principali |
Licensing-In | ● | Licensing-Out | ● | Co-development | ○ | Trading | ● | Drug Product CMO | ● | Other CMO Activities | ● |
|
-
Fasi di sviluppo |
Registration | ● | Market | ● | Generic | ● |
|
-
Aree terapeutiche |
Cardiovascular | ● | CNS | ● | Diabetes | ● | Gastrointestinal | ● | Gynaecology | ● | Metabolism | ● | Pain | ● | Rheumatology | ● | Other | ● |
|
-
-
-
Altre attività (non farmaceutiche) |
Analytical Services | ● | Distribution | ● | Medical Devices | ○ | Natural Products | ○ | Nutraceuticals | ○ |
|
-
Altre attività di CMO |
Analytical Services | ● | Co-development | ● | Other | ● |
|
Linkedin